T Ji1, C Feng2, L Sun3, X Ye4, Y Bai2, Q Chen2, Y Qin2, J Zhu5, X Zhao6. 1. Department of Geriatrics, Shanghai First People's Hospital Affiliated with Shanghai Jiaotong University, Shanghai, China. 2. Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai, China. 3. Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China. 4. Department of Health Statistics, Second Military Medical University, Shanghai, China. 5. Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai, China. zjq77324@126.com. 6. Department of Cardiology, Changhai Hospital, Second Military Medical University, Shanghai, China. 13601713431@163.com.
Abstract
BACKGROUND: Atrial fibrillation is the most common arrhythmia in clinical practice and is a major contributor to mortality. Recently, several studies have reported different results for treatments aimed at reducing the risk of postoperative AF. AIMS: The aim of this study was to evaluate the efficacy of beta-blockers (BBs) in preventing post-coronary artery bypass grafting (CABG) AF and to compare the efficacies of different BB treatments using a network meta-analytical approach. METHODS: The PubMed, EMBASE and Cochrane Library databases were searched (Jan 1995 to May 2014) to identify randomized controlled trials. Two independent investigators separately extracted the data using a seven-point scoring system to assess randomization, allocation concealment, blinding, withdrawals and dropouts. A direct meta-analysis of these randomized controlled trials was conducted. Then, six trials comparing different BB treatments for the prevention of postoperative AF were added to perform a Bayesian network meta-analysis with mixed treatment comparisons. RESULTS: Treatment with BBs was associated with a significant reduction in the postoperative incidence of AF compared with placebo/control [22.37 % compared with 34.45 %, relative risk (RR) = 0.53, 95 % confidence interval (CI): 0.37-0.75, p < 0.00001]. CONCLUSIONS: The network meta-analysis revealed no significant differences among eight types of BB treatments but did provide a ranking. BB treatments could significantly reduce the occurrence of post-CABG AF. Insufficient evidence was available to show that one BB treatment was more effective than the others were. According to our network meta-analysis, bisoprolol and landiolol+bisoprolol are better alternatives compared with the other treatments.
BACKGROUND:Atrial fibrillation is the most common arrhythmia in clinical practice and is a major contributor to mortality. Recently, several studies have reported different results for treatments aimed at reducing the risk of postoperative AF. AIMS: The aim of this study was to evaluate the efficacy of beta-blockers (BBs) in preventing post-coronary artery bypass grafting (CABG) AF and to compare the efficacies of different BB treatments using a network meta-analytical approach. METHODS: The PubMed, EMBASE and Cochrane Library databases were searched (Jan 1995 to May 2014) to identify randomized controlled trials. Two independent investigators separately extracted the data using a seven-point scoring system to assess randomization, allocation concealment, blinding, withdrawals and dropouts. A direct meta-analysis of these randomized controlled trials was conducted. Then, six trials comparing different BB treatments for the prevention of postoperative AF were added to perform a Bayesian network meta-analysis with mixed treatment comparisons. RESULTS: Treatment with BBs was associated with a significant reduction in the postoperative incidence of AF compared with placebo/control [22.37 % compared with 34.45 %, relative risk (RR) = 0.53, 95 % confidence interval (CI): 0.37-0.75, p < 0.00001]. CONCLUSIONS: The network meta-analysis revealed no significant differences among eight types of BB treatments but did provide a ranking. BB treatments could significantly reduce the occurrence of post-CABG AF. Insufficient evidence was available to show that one BB treatment was more effective than the others were. According to our network meta-analysis, bisoprolol and landiolol+bisoprolol are better alternatives compared with the other treatments.
Authors: Giuseppe Marazzi; Ferdinando Iellamo; Maurizio Volterrani; Giuseppe Caminiti; Mariapina Madonna; Giovanna Arisi; Rosalba Massaro; Daniela Righi; Giuseppe M C Rosano Journal: Am J Cardiol Date: 2010-12-02 Impact factor: 2.778
Authors: Eraldo de Azevedo Lúcio; Adriana Flores; Celso Blacher; Paulo E Leães; Fernando A Lucchese; Jorge Pinto Ribeiro Journal: Arq Bras Cardiol Date: 2004-02-12 Impact factor: 2.000
Authors: Cadman L Leggett; Emmanuel C Gorospe; Andrew D Calvin; William S Harmsen; Alan R Zinsmeister; Sean Caples; Virend K Somers; Kelly Dunagan; Lori Lutzke; Kenneth K Wang; Prasad G Iyer Journal: Clin Gastroenterol Hepatol Date: 2013-09-11 Impact factor: 11.382
Authors: Marina A Skiba; Adrian W Pick; Krishanu Chaudhuri; Michael Bailey; Henry Krum; Lachlan J Kwa; Franklin L Rosenfeldt Journal: Heart Lung Circ Date: 2013-03-01 Impact factor: 2.975